ENST00000366940.6:c.-230+38380A>G
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000366940.6(ESRRG):c.-230+38380A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.114 in 151,490 control chromosomes in the GnomAD database, including 1,259 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.11 ( 1259 hom., cov: 32)
Consequence
ESRRG
ENST00000366940.6 intron
ENST00000366940.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.800
Publications
5 publications found
Genes affected
ESRRG (HGNC:3474): (estrogen related receptor gamma) This gene encodes a member of the estrogen receptor-related receptor (ESRR) family, which belongs to the nuclear hormone receptor superfamily. All members of the ESRR family share an almost identical DNA binding domain, which is composed of two C4-type zinc finger motifs. The ESRR members are orphan nuclear receptors; they bind to the estrogen response element and steroidogenic factor 1 response element, and activate genes controlled by both response elements in the absence of any ligands. The ESRR family is closely related to the estrogen receptor (ER) family. They share target genes, co-regulators and promoters, and by targeting the same set of genes, the ESRRs seem to interfere with the ER-mediated estrogen response in various ways. It has been reported that the family member encoded by this gene functions as a transcriptional activator of DNA cytosine-5-methyltransferases 1 (Dnmt1) expression by direct binding to its response elements in the DNMT1 promoters, modulates cell proliferation and estrogen signaling in breast cancer, and negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation and bone formation. Multiple alternatively spliced transcript variants have been identified, which mainly differ at the 5' end and some of which encode protein isoforms differing in the N-terminal region. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.224 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ESRRG | NM_001134285.3 | c.-230+38380A>G | intron_variant | Intron 1 of 8 | NP_001127757.1 | |||
| ESRRG | NM_001243510.3 | c.-224+38380A>G | intron_variant | Intron 1 of 8 | NP_001230439.1 | |||
| ESRRG | NM_001243511.3 | c.-106+38380A>G | intron_variant | Intron 1 of 7 | NP_001230440.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.113 AC: 17177AN: 151372Hom.: 1257 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
17177
AN:
151372
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.114 AC: 17216AN: 151490Hom.: 1259 Cov.: 32 AF XY: 0.114 AC XY: 8466AN XY: 73948 show subpopulations
GnomAD4 genome
AF:
AC:
17216
AN:
151490
Hom.:
Cov.:
32
AF XY:
AC XY:
8466
AN XY:
73948
show subpopulations
African (AFR)
AF:
AC:
7901
AN:
41242
American (AMR)
AF:
AC:
1237
AN:
15172
Ashkenazi Jewish (ASJ)
AF:
AC:
255
AN:
3464
East Asian (EAS)
AF:
AC:
1209
AN:
5140
South Asian (SAS)
AF:
AC:
439
AN:
4812
European-Finnish (FIN)
AF:
AC:
763
AN:
10414
Middle Eastern (MID)
AF:
AC:
29
AN:
292
European-Non Finnish (NFE)
AF:
AC:
5116
AN:
67938
Other (OTH)
AF:
AC:
222
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
707
1414
2122
2829
3536
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
614
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.